孙天盟，博士，教授，博士生导师。主要从事纳米药物载体用于肿瘤免疫治疗和抗移植免疫排斥的研究工作，研究方向为开发改造免疫系统功能的智能纳米药物载体用于肿瘤免疫治疗及抗移植免疫排斥的研究。先后获得2014年“国家自然科学基金优秀青年科学基金”、2014年“吉林省长白山学者”特聘教授、2015年“国家自然科学基金面上项目”和2017年“国家重点研发项目（纳米科技，青年专项）”等项目资助。至今在国际学术刊物上发表SCI学术论文29篇，其中包括Science Translational Medicine，Angewandte Chemie International Edition，ACS Nano，Biomaterials等国际权威学术期刊，发表论文他引2800余次。  
                                                                                                                      

代表性文章：
[1]    X. Wu, H. M. Chen, C. X. Wu C, J. L. Wang, S. Zhang, J. Gao, H. D. Wang, T. M. Sun,* Y. G. Yang,* Inhibition of intrinsic coagulation improves safety and tumor-targeted drug delivery of cationic solid lipid nanoparticles. Biomaterials 2017, 156, 77-87
[2]    M. Gao,# F. Fan,# D. D. Li,# Y. Yu,* K. R. Mao, T. M. Sun,* H. S. Qian, W. Tao, X. Z. Yang,* Tumor Acidity-activatable TAT Targeted Nanomedicine for Enlarged Fluorescence/magnetic Resonance Imaging-guided Photodynamic Therapy. Biomaterials 2017, 133, 165-75                                                                                                                        
[3]    T. M. Sun, Y. S. Zhang, B. Pang, D. C. Hyun, M. Yang, Y. Xia,* Engineered Nanoparticles for Drug Delivery in Cancer Therapy. Angewandte Chemie International Edition 2014, 53, 12320-64                                                                                                                          
[4]   Y. D. Yao,# T. M. Sun,# S. Y. Huang, S. Dou, L. Lin, C. Q. Mao, F. Y. Yu, M. S. Zeng, J. Y. Zang, F. X. Su, P. Zhang, J. Lieberman,* J. Wang,* E. W. Song,* Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis. Science Translational Medicine 2012, 4, 30-48